Platelet-activating anti-PF4 disorders: An overview
Open Access
- 20 February 2022
- journal article
- research article
- Published by Elsevier in Seminars in Hematology
- Vol. 59 (2) , 59-71
Abstract
No abstract availableKeywords
This publication has 153 references indexed in Scilit:
- Rapid onset heparin-induced thrombocytopenia (HIT) without history of heparin exposure: A new case of so-called ‘spontaneous’ HITThrombosis and Haemostasis, 2012
- Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HITBlood, 2011
- PI-88: a novel inhibitor of angiogenesisExpert Opinion on Investigational Drugs, 2008
- Contaminated HeparinNew England Journal of Medicine, 2008
- Determinants of PF4/heparin immunogenicityBlood, 2007
- Heparin-Induced Thrombocytopenia Associated with FondaparinuxNew England Journal of Medicine, 2007
- Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopeniaBlood, 2005
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Heparin‐associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharidesBritish Journal of Haematology, 1993
- Immune Endothelial-Cell Injury in Heparin-Associated ThrombocytopeniaNew England Journal of Medicine, 1987